跳转至内容
Merck
CN

B7522

苯氟雷司 盐酸盐

analytical standard

别名:

N-(1-甲基-2-(3-[三氟甲基]-苯基)乙基]氨基乙醇苯甲酸酯

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C19H20F3NO2 · HCl
化学文摘社编号:
分子量:
387.82
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
245-801-8
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

NLOALSPYZIIXEO-UHFFFAOYSA-N

InChI

1S/C19H20F3NO2.ClH/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16;/h2-9,13-14,23H,10-12H2,1H3;1H

SMILES string

Cl.CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c2ccccc2

grade

analytical standard

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)

format

neat

Quality Level

Gene Information

human ... SOAT1(6646)

General description

Benfluorex hydrochloride salt is a hypolipidaemic compound with lipid and glucose lowering effects.
It is used in the treatment of impaired carbohydrate metabolism, atherogenic metabolic disorders and in the suppression of appetite.

Application

Benfluorex hydrochloride may be used as a reference standard for characterization of human urinary metabolites of benfluorex by gas chromatography–electron ionization–mass spectrometry (GC-EI-MS) as well as liquid chromatography–electrospray ionization–high resolution/high accuracy tandem mass spectrometry (LC-ESI-MS/MS) method.
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

监管及禁止进口产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Agnès Fournier et al.
Pharmacoepidemiology and drug safety, 21(4), 343-351 (2012-02-10)
To estimate the number of deaths from valvular insufficiency caused by the use of the fenfluramine-derivative benfluorex during the period 1976-2009 in France. Our calculation was based on (i) the exposure level to benfluorex in the French population, derived from
Screening for benfluorex and its major urinary metabolites in routine doping controls.
Thevis M, et al.
Analytical and Bioanalytical Chemistry, 401(2), 543-551 (2011)
Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs.
Maccaroni E, et al.
Journal of Pharmaceutical and Biomedical Analysis, 53(1), 1-6 (2010)
Can benfluorex induce congenital malformations?
I Lacroix et al.
Diabetes & metabolism, 38(4), 373-374 (2012-05-09)
Geneviève Derumeaux et al.
PloS one, 7(6), e38273-e38273 (2012-06-23)
REGULATE trial was designed to compare the efficacy and safety of benfluorex versus pioglitazone in type 2 diabetes mellitus (DM) patients. Double-blind, parallel-group, international, randomised, non-inferiority trial. More than half of the 196 participating centres were primary care centres. Patients

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持